The human amylin analog, pramlintide, corrects postprandial hyperglucagonemia in patients with type 1 diabetes. - Fineman,M.S.; Koda,J.E.; Shen,L.Z.; Strobel,S.A.; Maggs,D.G.; Weyer,C.; Kolterman,O.G. (Metabolism, 2002)